Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields
Advanced Science · 2026-11 · 13 (61)
DOI: 10.1002/advs.77172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.08.2026. Verfasst von Jiaxuan Cheng und 59 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Polysaccharides, Antibodies, Viral. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leidos Biomedical Research contracts, Frederick National Laboratory for Cancer Research, Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Viral entry glycoproteins are often shielded from immune recognition by dense N ‐linked glycans that limit antibody access to protein epitopes. While glycan‐reactive antibodies with unusual architectures have been described, how canonical Y‐shaped antibodies engage these glycan‐rich surfaces remains poorly defined. Here, we characterize two human antibodies, VRC35 and VRC36, isolated from an HIV‐1‐infected donor, that recognize diverse glycosylated viral glycoproteins. Cryo‐electron microscopy structural analyses of these antibodies in complex with viral entry glycoproteins, including HIV‐1 envelope, influenza hemagglutinin, SARS‐CoV‐2 spike, and the Lassa virus glycoprotein complex, reveal adaptive Fab stoichiometries ranging from single‐Fab binding to dimeric and higher‐order assemblies are mediated by intra‐ and inter‐IgG interactions that depend on local glycan organization. Dense glycan clustering on HIV‐1 and influenza glycoproteins supports multivalent Fab assemblies and correlates with neutralization activity, whereas sparse glycan environments on SARS‐CoV‐2 and Lassa virus favor weak or heterogeneous engagement without neutralization. Structural and mutational analyses further demonstrate that homotypic Fab–Fab interactions stabilize multivalent engagement and contribute to neutralizing activity. Together, these findings define a structural framework in which viral glycan organization constrains antibody valency and engagement, while somatic hypermutation contributes to the acquisition of homotypic Fab‐Fab interactions that facilitate multivalent recognition of viral glycan shields.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
- Department of Biochemistry and Molecular Biophysics and Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, USA.
- Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
- Drukier Institute for Children's Health, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
- Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Jiaxuan Cheng, Amirabbas Maghsoudi, Matthew S Sutton, Nancy S Longo, Sue Chong, Arne Schön, Prabhanshu Tripathi, Nicholas C Morano, Allison B Lupatkin, Myungjin Lee, Cuiping Liu, David J Van Wazer, Danyi Wang, Lingyuan Wu, Michael J Ernandes, Jonah S Merriam, Li Ou, Qi Qiu, Sarah Rubin, Andrea R Shiakolas, Sanjay Srivatsan, Mark Connors, Jason G Gall, Yicheng Guo, Q Paula Lei
Förderung
- Leidos Biomedical Research contracts
- Frederick National Laboratory for Cancer Research
- Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health
Zitieren
APA
Cheng, J., Cale, E. M., Maghsoudi, A., Sutton, M. S., Longo, N. S., Gillespie, R. A., Wang, L., Kosik, I., Chong, S., Yasuhara, A., Bylund, T., Schön, A., Tripathi, P., Tsybovsky, Y., Lei, H., Morano, N. C., Lupatkin, A. B., Morton, A. J., Lang, Z. C., …, & Mascola, J. R. (2026). Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. Advanced Science, 13(61). https://doi.org/10.1002/advs.77172
Vancouver
Cheng J, Cale EM, Maghsoudi A, Sutton MS, Longo NS, Gillespie RA, et al. Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. Advanced Science. 2026;13(61). doi:10.1002/advs.77172
BibTeX
@article{Cheng2026,
author = {Cheng, Jiaxuan and Cale, Evan M and Maghsoudi, Amirabbas and Sutton, Matthew S and Longo, Nancy S and Gillespie, Rebecca A and Wang, Lingshu and Kosik, Ivan and Chong, Sue and Yasuhara, Atsuhiro and Bylund, Tatsiana and Schön, Arne and Tripathi, Prabhanshu and Tsybovsky, Yaroslav and Lei, Haotian and Morano, Nicholas C and Lupatkin, Allison B and Morton, Abraham J and Lang, Zabrina C and Becker, Jordan E and Frascilla, Isabella R and Lee, Myungjin and Li, Ning and Liu, Cuiping and Roark, Ryan S and Shen, Chen-Hsiang and Teng, I-Ting and Van Wazer, David J and Wang, Danyi and Wu, Lingyuan and Ahlsen, Goran and Castro, Mike and Du, Haijuan and Ernandes, Michael J and Li, Tiansheng and Lin, Bob C and Louder, Mark K and McKee, Krisha and Merriam, Jonah S and O'Dell, Sijy and Ou, Li and Pletnev, Sergei and Prikryl, David and Qiu, Qi and Rubin, Sarah and Sastry, Mallika and Schmidt, Stephen D and Shajahan, Asif and Shiakolas, Andrea R and Srivatsan, Sanjay and Zhang, Baoshan and Zhou, Qiong and Connors, Mark and Gall, Jason G and Guo, Yicheng and Huang, Rick K and Huang, Yaoxing and Koup, Richard A and Lei, Q Paula and Mascola, John R},
title = {Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {61},
doi = {10.1002/advs.77172}
}
EUVIMED